Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$64.11
neg -0.78
-1.20%
Today's Range: 64.07 - 64.83 | BMY Avg Daily Volume: 6,735,500
Last Update: 07/30/15 - 10:27 AM EDT
Volume: 432,919
YTD Performance: 9.93%
Open: $64.55
Previous Close: $64.89
52 Week Range: $47.55 - $70.54
Oustanding Shares: 1,667,502,766
Market Cap: 107,820,728,850
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 4 4 4 5
Moderate Sell 0 0 0 0
Strong Sell 1 2 1 1
Mean Rec. 1.89 2.10 1.89 1.97
Latest Dividend: 0.37
Latest Dividend Yield: 2.29%
Dividend Ex-Date: 07/01/15
Price Earnings Ratio: 60.43
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
60.43 60.60 25.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.93% 27.21% 80.00%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 -0.25 -0.09
Net Income -21.40 -0.61 -0.27
EPS -22.20 -0.44 -0.18
Earnings for BMY:
EBITDA 3.06B
Revenue 15.88B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.33 $0.22 $1.80 $2.27
Number of Analysts 9 8 12 13
High Estimate $0.40 $0.27 $1.93 $2.49
Low Estimate $0.27 $0.13 $1.74 $2.05
Prior Year $0.45 $0.46 $1.85 $1.80
Growth Rate (Year over Year) -25.68% -51.90% -2.61% 25.87%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

David Peltier

 | Jul 22, 2015 | 4:41 PM EDT

Tech, telecom stocks lead major averages lower.

By

Sebastian Silva

 | Jul 19, 2015 | 7:39 PM EDT

Futures are mixed as quarterly results begin to obscure Greece.

By

David Peltier

 | Jul 17, 2015 | 4:46 PM EDT

IPO makes big debut as Google soars.

By

Jim Cramer

 | Jul 13, 2015 | 6:13 AM EDT

This market is almost entirely special situation.

By

Jim Cramer

 | Jul 5, 2015 | 6:15 PM EDT

Is there also a lot on the line for the U.S.?

By

Robert Moreno

 | Jul 2, 2015 | 12:45 PM EDT

Stock is showing short-term positive price momentum.

By

Roger Arnold

 | Jun 25, 2015 | 1:46 PM EDT

As health-care stocks rally, it's time for politicians to move on.

By

Paul Price

 | Jun 23, 2015 | 8:30 AM EDT

Company behind Enfamil could satisfy your appetite for gains.

By

Jim Cramer

 | Jun 22, 2015 | 2:04 PM EDT

Don't rely on Europe; it's too out of sync with U.S.

By

Sebastian Silva

 | Jun 17, 2015 | 3:10 PM EDT

Jim Cramer recently shared his insight on some of the best potential takeover targets, and we're taking his lead and looking at how his picks...

The IMF/Greece news triggers higher bond prices, lower yields.

Second quarter GDP comes in at 2.3%, first quarter GDP is revised up to .6%. This means G...
On this earnings call and being honest, I mostly have no idea what the company is talking ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.